Instituto Hermes Pardini SA
BOVESPA:PARD3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Instituto Hermes Pardini SA
BOVESPA:PARD3
|
BR |
|
H
|
Hutchison Telecommunications Hong Kong Holdings Ltd
SWB:4C6
|
HK |
|
Cineplex Inc
TSX:CGX
|
CA |
|
P
|
Polymac Thermoformers Ltd
BSE:537573
|
IN |
|
Compagnie De l'odet SE
PAR:ODET
|
FR |
|
S
|
Stelrad Group PLC
LSE:SRAD
|
UK |
|
I
|
Imagis Co Ltd
KOSDAQ:115610
|
KR |
|
J
|
Jay Bharat Maruti Ltd
NSE:JAYBARMARU
|
IN |
|
M
|
Mecaro Co Ltd
KOSDAQ:241770
|
KR |
|
J
|
Johnson Electric Holdings Ltd
OTC:JELCF
|
HK |
Relative Value
There is not enough data to reliably calculate the relative value of PARD3.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PARD3 Competitors Multiples
Instituto Hermes Pardini SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Instituto Hermes Pardini SA
BOVESPA:PARD3
|
2.6B BRL | 1.2 | 15 | 6.2 | 9.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
90.6B USD | 0.2 | 51.2 | 13.4 | 13.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.7B EUR | 0.3 | 12.9 | 7.6 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
68.9B USD | 0.3 | 11.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.8B EUR | 1.1 | 19.7 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.7B EUR | 1.1 | 22.8 | 8.8 | 16.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.8 | 11.9 | 17.3 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 1.9 | 21.8 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR | 0.5 | 10.9 | 5.3 | 9.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.1B USD | 11.3 | -26.7 | -29.2 | -26.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 14 | 7.2 | 9.8 |